|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Receivables from affiliates of Natura &Co | ||||||||||||||||||||
| Loans to affiliates of Natura &Co | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other | ||||||||||||||||||||
| Held for sale assets | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Held-for-sale | ||||||||||||||||||||
| Total current assets of discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Equipment | ||||||||||||||||||||
| Property, plant and equipment, at cost | ||||||||||||||||||||
| Less accumulated depreciation | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Loans to affiliates of Natura &Co | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Deficit | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Debt maturing within one year | ||||||||||||||||||||
| Loans from affiliates of Natura &Co | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Payables to affiliates of Natura &Co | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||||
| Sales taxes and taxes other than income | ||||||||||||||||||||
| Income taxes | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Discontinued Operations | ||||||||||||||||||||
| Held-for-sale | ||||||||||||||||||||
| Total current liabilities of discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Loans from affiliates of Natura &Co | ||||||||||||||||||||
| Long-term operating lease liability | ||||||||||||||||||||
| Employee benefit plans | ||||||||||||||||||||
| Long-term income taxes | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Series C convertible preferred stock | ||||||||||||||||||||
| Shareholders’ Deficit | ||||||||||||||||||||
| Common stock - par value $0.01 per share - 101.34 outstanding at each period end | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Total Avon shareholders’ deficit | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total shareholders’ deficit | ||||||||||||||||||||
| Total liabilities and shareholders’ deficit | ||||||||||||||||||||
Loading...
